The European Medical Journal 01/21/2026 article entitled “Both long and short sleep duration linked to liver disease” has new information.
Key Findings
- A recent population-level analysis found that both short and long habitual sleep durations are associated with signs of chronic liver disease, compared with moderate sleep duration.
- Short sleepers showed higher liver enzymes and higher fibrosis risk scores, indicating worse liver injury markers.
- Long sleep duration was also linked to adverse liver markers, although the association was weaker than for short sleep.
Interactions With Metabolic Risk Factors
- Associations were strongest in people with obesity, type 2 diabetes, or metabolic syndrome, suggesting sleep problems may worsen metabolic stress on the liver.
- Proposed mechanisms include effects on glucose metabolism, inflammation, and circadian rhythm disruption, all of which are known to influence liver physiology.
Clinical Implications
- The research supports considering sleep habits alongside traditional lifestyle factors (diet, exercise) in liver health assessments, particularly in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) or other chronic liver conditions.
- While causality wasn’t shown, sleep is suggested as a modifiable risk factor worth addressing in holistic liver care.
Future Directions
- Authors call for prospective and interventional studies to determine whether improving sleep can prevent or slow liver disease progression.